Difference between revisions of "Profiles"

From QIBA Wiki
Jump to navigation Jump to search
m
Line 17: Line 17:
  
  
''Public Comment closed''
+
'''''Public Comment closed'''''
 
* [[Media:DCEMRIProfile v1 6-20111213.pdf|DCE-MRI Quantification 2011-12-13]] (''Public Comment ended Feb 2012'')
 
* [[Media:DCEMRIProfile v1 6-20111213.pdf|DCE-MRI Quantification 2011-12-13]] (''Public Comment ended Feb 2012'')
 
*[[Media:001.QIBA SPECT Profile.v0.1 2016.10.28.docx | Quantifying Dopamine Transporters with 123 - Iodine Labeled Ioflupane in Neurodegenerative Disease Profile (v1.0), October 28, 2016]] (''Public Comment ended Feb 2017'')
 
*[[Media:001.QIBA SPECT Profile.v0.1 2016.10.28.docx | Quantifying Dopamine Transporters with 123 - Iodine Labeled Ioflupane in Neurodegenerative Disease Profile (v1.0), October 28, 2016]] (''Public Comment ended Feb 2017'')
Line 27: Line 27:
  
 
*[[Media:QIBA Small Nodule Profile References - Precision.xlsx|QIBA Spreadsheet: Small Nodule Profile References_Precision. Version for Public Comment. June 1, 2016]]
 
*[[Media:QIBA Small Nodule Profile References - Precision.xlsx|QIBA Spreadsheet: Small Nodule Profile References_Precision. Version for Public Comment. June 1, 2016]]
 +
  
 
==Statements of Endorsement==
 
==Statements of Endorsement==

Revision as of 22:45, 23 June 2017

Profiles published here have completed one of the QIBA Profile Stages of development and been approved by their Biomarker Committee.

Stage 3: Technically Confirmed Profiles

Stage 2: Consensus Profiles

Stage 1: Public Comment Profiles

Link to QIBA Public Comment Form: http://tinyurl.com/y8dy2pc2


Public Comment closed


Statements of Endorsement


See Also